Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3260

Actual shortage: 240 (7%)
Anticipated shortage: 6 (0%)
Avoided shortage: 9 (0%)
Resolved: 3005 (92%)

Discontinuation Reports

355

To be discontinued: 22 (6%)
Discontinued: 333 (94%)
Reversed: 0 (0%)

Late reports

143 (4%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-04-12 2024-04-19 224984
APO-PANTOPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-05-03 2024-05-31 227034
APO-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-05-03 2024-05-31 227073
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2024-06-06 2024-10-18 229776
APO-ESOMEPRAZOLE 20MG TABLET (DELAYED-RELEASE) Resolved 2024-07-12 2024-08-09 232815
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Actual shortage 2024-08-01 2024-12-04 234271
APO-PANTOPRAZOLE 20MG TABLET (DELAYED-RELEASE) Actual shortage 2024-09-20 2024-10-31 238236
APO-PANTOPRAZOLE 20MG TABLET (DELAYED-RELEASE) Actual shortage 2024-10-24 2024-10-31 241069
APO-PANTOPRAZOLE 40MG TABLET (DELAYED-RELEASE) Actual shortage 2024-12-05 2024-12-05 244896
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2017-03-11 2017-05-23 466
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Resolved 2017-04-11 2017-05-25 6516
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2017-06-06 2017-07-17 12059
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2017-06-15 2017-07-26 12805
APO-RABEPRAZOLE 20MG TABLET (ENTERIC-COATED) Resolved 2017-07-11 2017-07-27 15375
APO-NAPROXEN EC 500MG TABLET (ENTERIC-COATED) Resolved 2017-09-04 2018-07-31 20882
APO-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Resolved 2018-01-03 2018-02-12 34844
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2018-01-03 2018-03-06 34847
APO-NAPROXEN EC TABLETS 250MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-05-01 40351
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2018-02-21 2018-08-09 40354
APO-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Resolved 2018-04-16 2018-05-14 46024

Showing 2901 to 2920 of 3260

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-IRBESARTAN/HCTZ Discontinued 2018-02-23 2018-07-17 40763
APO-CETIRIZINE Discontinued 2018-05-31 2018-05-31 50998
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-09-07 2018-09-15 60241
APO-CYCLOSPORINE ORAL SOLUTION Discontinued 2018-09-07 2018-09-15 60408
APO-FAMOTIDINE TAB 20MG USP Discontinued 2018-09-07 2018-09-15 60477
APO-FAMOTIDINE TAB 40MG USP Discontinued 2018-09-07 2018-09-15 60480
APO-FENTANYL MATRIX Discontinued 2018-09-07 2018-09-15 60494
APO-IRBESARTAN/HCTZ Discontinued 2018-09-07 2018-09-15 60548
APO-LATANOPROST-TIMOP Discontinued 2018-09-07 2018-09-15 60572
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60735
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60738
APO-REPAGLINIDE Discontinued 2018-09-08 2018-09-15 60741
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-AMOXI CLAV 125MG/31.25MG PER 5ML Discontinued 2018-12-21 2018-12-24 70347
APO-TIMOP Discontinued 2019-01-02 2019-01-02 70818
ACID CONTROL Discontinued 2019-01-03 2019-01-03 70906
APO-OFLOXACIN Discontinued 2019-01-03 2019-01-03 71017
APO-TIMOP GEL Discontinued 2019-01-03 2019-01-03 71020
APO-VALSARTAN Discontinued 2019-01-03 2019-01-03 71029

Showing 1 to 20 of 355